Beyond the Basics: Systemic Treatment for Atopic Dermatitis and Evaluation of Infantile Hemangiomas
Infantile Hemangiomas To kick off ODAC 2021, Dr. Yasmine Kirkorian, MD, tackled two clinical dilemmas that are frequently seen among pediatric patients in the dermatology office: poorly controlled atopic dermatitis and infantile hemangiomas. Dr. Kirkorian reviewed currently available systemic therapies for atopic dermatitis as well those in the drug development pipeline. She went into detail about how she utilizes he …
Infantile Hemangiomas
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
JAK InhibitorsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …
JAK Inhibitors
Controversies in Pediatric Dermatology: Systemic Therapies
Controversies in Pediatric DermatologyDr. Yasmine Kirkorian, Interim Chief of Dermatology at Children's National Health System and Assistant Professor of Dermatology and Pediatrics at the George Washington School of Medicine & Health Sciences, summarizes recent controversies in the field of pediatric dermatology regarding the usage of systemic therapies in children. This article will provide an overview of the following: …
Controversies in Pediatric Dermatology
Complexities of Managing Inflammatory Diseases – A Case-Based Review (Dr. Friedman’s ODAC lecture)
It’s time for a review of Dr. Adam Friedman’s presentation, “Complexities of Managing Inflammatory Diseases,” which was another one of the popular lectures from ODAC 2018. This lecture was case-based and full of helpful pearls. So let’s get to it! CASE #1: 70-year-old female with red, pruritic “rash” involving her face, trunk, and extremities for several months. The rest of her hi …
Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
Cheilitis Granulomatos INTRODUCTION Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and sarcoidosis.1 With concurrent facial palsy and a plicated tongue, the condition is referred to as Melkersson-Rosenthal syndrome.1,2 Both CG and Melkersson-Rosenthal syndrome are in the …
Cheilitis Granulomatos
error

Enjoy this blog? Please spread the word :)